drug protocol number

RC12/052/R

drug sponsor

KAIMRC

drug study

NILOTINIB

drug trial site

King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam)

drug status

Ongoing

drug phase